Last updated on October 2017

A Single Escalating Dose Study of BAY 1093884 in Subjects With Severe Hemophilia Types A or B With or Without Inhibitors

Brief description of study

Investigate the safety, tolerability and pharmacokinetics of BAY 1093884 after Intravenous (IV) and subcutaneous (SC) administration of increasing single doses.

Clinical Study Identifier: NCT02571569


Contact Investigators or Research Sites near you

Start Over